Below is a corrected version of the dividend payment timetable contained in note 16 of the preliminary results statement for the year ended 31 December 2024, issued earlier today at 7:00 am under RNS No 5084G. The timetable for the payment of the final dividend has been corrected. All other details remain the same.
ANIMALCARE GROUP PLC
(the "Company" or the "Group")
Final Dividend Timetable
29 April 2025. The Board is proposing a final dividend of 3.0 pence per share (2023: 3.0 pence per share). Subject to shareholder approval at the Annual General Meeting to be held on 10 June 2025, the final dividend will be paid on 18 July 2025 to shareholders whose names are on the Register of Members at close of business on 20 June 2025. The ordinary shares will become ex-dividend on 19 June 2025.
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com or contact:
|
Animalcare Group Plc Jenny Winter, Chief Executive Officer |
+44 (0)1904 487 687
communications@animalcaregroup.com |
|
Stifel Nicolaus Europe Limited (Nominated Advisor & Joint Broker) Ben Maddison Nicholas Harland Francis North |
+44 (0)20 7710 7600
|
|
Panmure Liberum (Joint Broker) Corporate Finance Freddy Crossley/Emma Earl Corporate Banking Rupert Dearden |
+44 (0)20 7886 2500 |
|
Alma Strategic Communications Caroline Forde Kinvara Verdon Rose Docherty |
+44 (0)20 3405 0205 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
